CellCarta, formely Caprion-HistoGeneX.
CellCarta is a leading provider of specialized precision medicine laboratory services to the biopharmaceutical industry. Leveraging its integrated analytical platforms in immunology, histopathology, proteomics and genomics, as well as related specimen collection and logistics services, CellCarta supports the entire drug development cycle, from discovery to late stage clinical trials.
The company operates globally with 9 facilities located in Canada, USA, Belgium, Australia, and China.
Location: Canada, Montreal (06), Montreal
Member count: 501-1000
Phone: +1 514-360-3600
Founded date: 2000
Investors 1
| Date | Name | Website |
| 27.01.2021 | Arsenal Ca... | arsenalcap... |
Mentions in press and media 3
| Date | Title | Description | Category | Author | Source |
| 19.05.2022 | CellCarta ... | This acquisition solidifies Ce... | - | - | en.prnasia... |
| 17.03.2022 | physIQ, Ce... | What You Should Know: – Today... | - | Jasmine Pe... | hitconsult... |
| 17.01.2022 | Fast, Meta... | A large variety of metadata-dr... | - | - | prweb.com/... |